BibTex RIS Kaynak Göster

Malign Pleural Effusion In A Patient With Multiple Myeloma,

Yıl 2011, Cilt: 25 Sayı: 1, 43 - 45, 01.04.2011

Öz

Kaynakça

  • Kyle RA, Rajkumar SV. Multiple myeloma; in Goldman L, Ausiello DA (eds): Cecil Textbook of Medicine, ed 22. Philadelphia, Saunders, 2004;1184–1195.
  • John CH, May LV. Pleural effusion in multiple myeloma. Cancer 1979;44: 1150-1154.
  • Meoli A, Willsie S, Fiorella R. Myelomatous pleural effusion. South Med J 1997; 90: 65–68.
  • Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol 2000; 22: 147–151.
  • Alexandrakis MG, Passam FH, Kyriakou DS and Bouros D. Pleural effusions in hematologic malignancies. Chest 2004;125:1546 – 1555.
  • VSS Attili, VP Singh, S Sundar, et al. Malignant myelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007;55:595-596.
  • Abbate SL, Jaff MR, Fishleder AJ, et al. Lambda light chain myeloma with pleural involvement. Cleve Clin Med 1991;58:235-239.
  • Kim YJ, Kim SJ, Min K, et al. Multiple Myeloma with Myelomatous Pleural Effusion: A Case Report and Review of the Literature. Acta Haematol 2008;120:108–111.
  • Gogia A, Agarwal PK, Jain S, Jain KP. Myelomatous Pleural Effusion. J Assoc Physicians India 2005;53:734-736.
  • Kamble R, Wilson CS, Fassas A. Malignant pleural effusion of myeloma: Prognostic factors and outcome. Leuk Lymph 2005;46:1137-1142.

Malign Pleural Effusion In A Patient With Multiple Myeloma,

Yıl 2011, Cilt: 25 Sayı: 1, 43 - 45, 01.04.2011

Öz

Malign plevral effüzyon, multiple myelomda progresyonla karekterize ve geç gelişen bir komplikasyondur. Tanıdan sonra ortalama yaşam süresi 4 aydır ve sistemik kemoterapilere oldukça dirençlidir. Biz bu makalede 49 yaşında tanıdan 4 ay sonra malign plevral effüzyon gelişen ve solunum yetmezliği nedeniyle kaybedilen bir hastayı sunuyoruz

Kaynakça

  • Kyle RA, Rajkumar SV. Multiple myeloma; in Goldman L, Ausiello DA (eds): Cecil Textbook of Medicine, ed 22. Philadelphia, Saunders, 2004;1184–1195.
  • John CH, May LV. Pleural effusion in multiple myeloma. Cancer 1979;44: 1150-1154.
  • Meoli A, Willsie S, Fiorella R. Myelomatous pleural effusion. South Med J 1997; 90: 65–68.
  • Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol 2000; 22: 147–151.
  • Alexandrakis MG, Passam FH, Kyriakou DS and Bouros D. Pleural effusions in hematologic malignancies. Chest 2004;125:1546 – 1555.
  • VSS Attili, VP Singh, S Sundar, et al. Malignant myelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007;55:595-596.
  • Abbate SL, Jaff MR, Fishleder AJ, et al. Lambda light chain myeloma with pleural involvement. Cleve Clin Med 1991;58:235-239.
  • Kim YJ, Kim SJ, Min K, et al. Multiple Myeloma with Myelomatous Pleural Effusion: A Case Report and Review of the Literature. Acta Haematol 2008;120:108–111.
  • Gogia A, Agarwal PK, Jain S, Jain KP. Myelomatous Pleural Effusion. J Assoc Physicians India 2005;53:734-736.
  • Kamble R, Wilson CS, Fassas A. Malignant pleural effusion of myeloma: Prognostic factors and outcome. Leuk Lymph 2005;46:1137-1142.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

A. Katgı Bu kişi benim

S. Kahraman Bu kişi benim

P. Ataca Bu kişi benim

Ö. Pişkin Bu kişi benim

M. A. Özcan Bu kişi benim

G. H. Özsan Bu kişi benim

F. Demirkan Bu kişi benim

B. Ündar Bu kişi benim

Yayımlanma Tarihi 1 Nisan 2011
Gönderilme Tarihi 11 Ağustos 2015
Yayımlandığı Sayı Yıl 2011 Cilt: 25 Sayı: 1

Kaynak Göster

Vancouver Katgı A, Kahraman S, Ataca P, Pişkin Ö, Özcan MA, Özsan GH, Demirkan F, Ündar B. Malign Pleural Effusion In A Patient With Multiple Myeloma,. DEU Tıp Derg. 2011;25(1):43-5.